80SBio
Biotechnology Research • 
Basel, Basel, Switzerland • 1-10 Employees
Company overview
| Headquarters | Spitalstrasse 41, C/o Biozentrum, Basel, Basel stadt 4056, CH |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 1-10 |
Key Contact at 80SBio
Arka Banerjee
Co-founder and CEO
About 80SBio
80SBio is a University of Basel spin-off revolutionizing RT-qPCR reactions for research and diagnostics. Our first product “UniqRT” is the first add-sample-and-load precision RT-qPCR system for research labs, which saves sample processing time and sample volume for researchers, while offering unprecedented accuracy.
$
80SBio revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
80SBio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
80SBio has never raised funding before.
Belgium
United States
SpainFrequently asked questions
80SBio is located in Basel, Basel, CH.
80SBio was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
80SBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
